This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Daniel Sandoval
Introduction
Daniel Sandoval is an accomplished inventor based in La Jolla, California. He has made significant strides in the field of antiviral therapeutics. His work focuses on the application of microbial glycosidase, which has the potential to diagnose, prevent, and treat viral infections.
Latest Patents
Daniel Sandoval holds a patent for the "Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic." This patent outlines methods and compositions for diagnosing, preventing, or treating viral infections. It specifically involves administering an effective amount of a glycosidase or a sulfatase to degrade glycans, such as heparan sulfate, to inhibit viral infections, including COVID-19.
Career Highlights
Sandoval is affiliated with the University of California, where he continues to contribute to research and innovation in the field of virology. His work is crucial in developing new therapeutic strategies against viral infections.
Collaborations
Some of his notable coworkers include Cameron Martino and Benjamin Kellman. Their collaborative efforts enhance the research environment and foster innovation in their projects.
Conclusion
Daniel Sandoval's contributions to antiviral therapeutics exemplify the importance of innovation in addressing global health challenges. His patent and ongoing research hold promise for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile